Panacea Life Sciences Holdings, Inc. Convertible Notes Payable
Panacea Life Sciences Holdings, Inc. (PLSH) had Convertible Notes Payable of $115.00 thousand as of 2023-12-31, per its 10-Q filed 2024-05-06.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2024-05-06
- 2023-12-31: Convertible Notes Payable $115.00K.
- 2023-09-30: Convertible Notes Payable $115.00K.
- 2023-06-30: Convertible Notes Payable $115.00K.
- 2023-03-31: Convertible Notes Payable $115.00K.
| Period end | Convertible Notes Payable |
|---|---|
| 2023-12-31 | $115.00K 10-Q · filed 2024-05-06 |
| 2023-09-30 | $115.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $115.00K 10-Q · filed 2023-08-15 |
| 2023-03-31 | $115.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $346.67K 10-K · filed 2024-04-01 |
| 2020-12-31 | $646.04K 10-K/A · filed 2021-04-23 |
| 2020-09-30 | $608.43K 10-Q · filed 2020-11-18 |
| 2020-06-30 | $575.98K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $402.21K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $185.91K 10-K/A · filed 2021-04-23 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $591.79K 10-K · filed 2020-05-22 |